Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 541

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 541
---
 Form of PIPE Subscription Agreement Exhibit D – Forfeiture Agreement Exhibit E – Form of Amended and Restated Registration Rights Agreement Exhibit F – Form of Convertible Notes Subscription Agreement Exhibit G – Form of Convertible Notes

A-iii

TABLE OF CONTENTS

### BUSINESS COMBINATION AGREEMENT
This Business Combination Agreement (this “ Agreement ”) is made and entered into as of November 30, 2022 (the “ Effective Date ”), by and among Iris Acquisition Corp, a Delaware corporation (the “ SPAC ”), Iris Parent Holding Corp., a Delaware corporation (“ ParentCo ”), Liminatus Pharma, LLC, a Delaware limited liability company (the “ Company ”), Liminatus Pharma Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of ParentCo (“ Liminatus Merger Sub ”), and SPAC Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of ParentCo (“ SPAC Merger Sub ” and together with Liminatus Merger Sub, the “ Merger Subs ”). Each of SPAC, ParentCo, SPAC Merger Sub, Liminatus Merger Sub, and the Company is also referred to herein as a “ Party ” and, collectively, as the “ Parties ”.

### RECITALS
WHEREAS, SPAC is a blank check special purpose acquisition company incorporated for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more operating businesses or entities through a business combination;

WHEREAS, ParentCo is a newly formed entity, and each of Liminatus Merger Sub and SPAC Merger Sub is a newly formed and wholly-owned direct subsidiary of ParentCo;

WHEREAS, upon the terms and subject to the conditions of this Agreement and in accordance with the General Corporation Law of the State of Delaware (the “ DGCL ”) and the Delaware Limited Liability Company Act (“ DLLC Act ”), as applicable, as part of an integrated transaction with the formations of ParentCo, Liminatus Merger Sub and SPAC Merger Sub; SPAC, ParentCo, Liminatus Merger Sub, SPAC Merger Sub and the Company will enter into a business combination transaction pursuant to which (a) Liminatus Merger Sub will merge with and into the Company (the “ Company Merger ”), with the Company surviving the Company Merger as a direct wholly-owned subsidiary of ParentCo, and (b) simultaneously